A Retrospective Multicenter Study of HBV-related Pre-acute-on-chronic Liver Failure in China
NCT03281265 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1178
Last updated 2018-01-23
Summary
The definition and diagnostic criteria of Acute-on-chronic liver failure (ACLF) has been well established by EASL CANONIC study. However, patients with high risk to develop ACLF has not been determined, yet. The aim of current study is to establish a preliminary pre-ACLF definition, and to demonstrate the corresponding risk factors.
Conditions
- Liver Failure, Acute on Chronic
- Liver Injury
Interventions
- OTHER
-
standard treatment
Sponsors & Collaborators
-
Nanfang Hospital, Southern Medical University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-01
- Primary Completion
- 2017-02-28
- Completion
- 2017-02-28
More Related Trials
-
Platelet Transfusion in Acute-on Chronic Liver Failure
NCT04564651 ·Status: UNKNOWN ·Phase: NA
-
Individual Nutrition Support in HBV-ACLF Patients at Nutrition Risk
NCT06128421 ·Status: RECRUITING ·Phase: NA
-
Acute on Chronic Liver Failure in Cirrhotic Patients at Assiut University Hospitals
NCT06142968 ·Status: NOT_YET_RECRUITING
-
Prognostic Significance of Acute Change in Liver and Splenic Stiffness in Patients of Acute on Chronic Liver Failure
NCT06069284 ·Status: UNKNOWN
-
Predicting Acute-on-Chronic Liver Failure in Cirrhosis (PREDICT) Study
NCT03056612 ·Status: COMPLETED
-
Pattern of Acute on Chronic Liver Failure in Patient With HCV Related Chronic Liver Disease
NCT03456518 ·Status: COMPLETED
-
Bacterial Infections in Cirrhotic Patients With Acute Severe Liver Injury
NCT03204591 ·Status: UNKNOWN
-
A Multi-Center Trial to Study Acute Liver Failure in Adults
NCT00518440 ·Status: COMPLETED
-
Efficacy of Early Terlipressin Plus Albumin Therapy in Comparison to Standard Treatment for HRS-AKI in Acute-on-chronic Liver Failure.
NCT04416282 ·Status: COMPLETED ·Phase: NA
-
Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLF
NCT04597164 ·Status: RECRUITING
-
Characterization of Metabolomic Fingerprints in Patients With Acute Liver Failure and Acute-on-chronic Liver Failure With Hepatic Encephalopathy
NCT05772585 ·Status: WITHDRAWN
-
To Study the Clinical Course and Outcomes of Non-electively Hospitalised Patients of Chronic Liver Disease (CLD) With Hepatic or Extra-hepatic Predominant Organ Failure(s) at 6 Months.
NCT07270809 ·Status: NOT_YET_RECRUITING
-
Neutrophil to Lymphocyte Ratio and Mean Platelet Volume as a Prognostic Predictor Among Patients With Acute on Top of Chronic Liver Cell Failure
NCT06857682 ·Status: ACTIVE_NOT_RECRUITING
-
Etiology and Prognostic Analysis of Acute Liver Failure in Chinese Children
NCT06778941 ·Status: NOT_YET_RECRUITING
-
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
NCT04613921 ·Status: RECRUITING
-
Exploring Biomarkers Predicting the Outcome of Acute-on-chronic Liver Failure
NCT02965560 ·Status: COMPLETED
-
Natural History of Advanced Chronic Liver Diseases
NCT07042308 ·Status: RECRUITING
-
Predictive Utility of DASIMAR as a Prognostic Biomarker in Acute-on-chronic Liver Failure (ACLF)
NCT01071746 ·Status: UNKNOWN
-
Biomarkers in Liver Failure
NCT02833064 ·Status: ACTIVE_NOT_RECRUITING
-
Immune Profile, Neuronal Dysfunction, Metabolomics and Ammonia in Therapeutic Response of HE in ACLF
NCT05421351 ·Status: UNKNOWN
-
Usefulness of the Variation of the CLIF-C ACLF Score in Patients With Acute on Chronic Liver Failure
NCT04186572 ·Status: UNKNOWN
-
Unknown Cause of Acute Liver Failure
NCT02041637 ·Status: COMPLETED
-
Effect of Goal Directed Ammonia Lowering Therapy in Acute on Chronic Liver Failure Patients With Hepatic Encephalopathy.
NCT02321371 ·Status: COMPLETED ·Phase: NA
-
Re-compensation and Its Clinical Characteristics in HBV Decompensated Cirrhosis
NCT05086536 ·Status: UNKNOWN
-
To Study the Role of Plasma Von Willebrand Factor Antigen (vWF) to A Disintegrin-like and Metalloproteinase With Thrombospondin Type-1 Motifs 13 (ADAMTS-13) Activity Ratio as a Predictor of Development of Extrahepatic Organ Failure in Acute on Chronic Liver Failure (ACLF) Patients.
NCT06066814 ·Status: UNKNOWN